University of Pennsylvania
Philadelphia, Pennsylvania
Private University
Founded 1740
Penn is a major research university with strong commercialization in biomedical sciences, gene therapy, and financial technology.
$2.2B
R&D (FY2024)
108
US Patents (2025)
26
Startups (FY2025)
$172.6M
Business-Funded R&D
Research and Commercialization Data
Total R&D Expenditures
5-Year Change: 37.2%
Avg: 1824.8
- Research spending (FY2024): $2.2B total, of which $172.6M was funded by business. NSF National Center for Science and Engineering Statistics
- US patents granted (2025): 108 (rank #16). National Academy of Inventors
- Tech transfer (FY2025): 26 startups. Penn Center for Innovation
Research Focus Areas
Gene Therapy & Genomics
Gene editing and inherited disease treatment
Perelman School of MedicineGene Therapy Program
Biomedical Engineering
Wearables, diagnostics, and implantables
Bioengineering
Neuroscience
Brain disorders and cognitive science
Penn Neuroscience
Related Market Maps
Explore market opportunities in deep tech categories relevant to Penn's research focus.
Neurotechnology
13% CAGRTechnologies interfacing with the nervous system for medical and research applications
Market Size$17.3B
Biotechnology
13.96% CAGRApplication of biological systems and organisms to develop products and technologies
Market Size$1.55T
Notable Spinouts
Spark Therapeutics
Founded 2013 • Biotechnology
Gene therapy company for inherited diseases
$4.3B deal valueby Roche
Visit sitePrograms & Resources
Tech Transfer Office
Penn Center for Innovation (PCI)
IP Portfolio Available
~532 technologies available for licensing
Gene TherapyBiomedicalPharmaceuticals
Platform: Custom
Browse IP PortfolioServices Offered
- •IP management
- •Licensing
- •Startup formation
- •Industry partnerships
Interested in Tech Transfer?
Learn how to navigate university licensing and commercialization